Results 201 to 210 of about 51,241 (251)
Some of the next articles are maybe not open access.
Stroke Mimics and Intravenous Thrombolysis
Annals of Emergency Medicine, 2012The necessity for rapid administration of intravenous thrombolysis in patients with acute ischemic stroke may lead to treatment of patients with conditions mimicking stroke. We analyze stroke patients treated with intravenous thrombolysis in our center to characterize cases classified as stroke mimics.We identified and reviewed all cases with a ...
Meretoja Atte +17 more
openaire +4 more sources
Intravenous thrombolysis in Sneddon’s syndrome
Journal of Clinical Neuroscience, 2012Sneddon's syndrome (SS) is an uncommon disorder, characterized by the association of ischemic stroke and widespread livedo reticularis. The treatment options for SS to prevent stroke recurrence and future disability include antiplatelet therapy, anticoagulation, or immunosuppression.
Jianzhong, Sun +5 more
openaire +2 more sources
Intravenous thrombolysis for acute stroke
Neurology, 1997Until recently there was no specific therapy for stroke, but the recent publication of the National Institute of Neurological Disorders and Stroke(NINDS) t-PA for Acute Stroke Trial presents the first effective, specific therapy for stroke.1 In considering whether to apply thrombolysis to any given patient, the physician must consider the factors ...
P D, Lyden +5 more
openaire +2 more sources
Intravenous Thrombolysis in Acute Myocardial Infarction
Chest, 2001(CHEST 2001; 119:253S‐277S) F ibrinolytic therapy for acute myocardial infarction (MI) has been one of the most potent treatments ever developed for a condition that kills more patients worldwide than any other. This review will focus on approved agents and the randomized trials that have led to their widespread use.
Ohman E. +5 more
openaire +3 more sources
Cerebral Perfusion Imaging for Intravenous Thrombolysis Treatment
Topics in Magnetic Resonance Imaging, 2021Abstract Intravenous thrombolysis is the cornerstone of acute ischemic stroke treatment. However, the benefits of recanalization and reperfusion must be balanced against the risk of intracranial hemorrhage. Time from symptom onset was previously the most important selection tool for identifying patients who would benefit from ...
Diana E, Slawski Md +1 more
openaire +2 more sources
Intravenous Thrombolysis for Acute Ischemic Stroke
Continuum, 2023This article reviews the history of IV thrombolysis, its current indications and implementation, the duality of the "time is brain" versus "tissue clock" approaches, the impact of endovascular thrombectomy on IV thrombolysis, the emergence of tenecteplase, and future research directions.The growing use of factor Xa inhibitors has increasingly caused ...
openaire +2 more sources
2010
This chapter will review the basic mechanisms of clot formation (thrombosis) and dissolution (thrombolysis or fibrinolysis), the mechanisms of the major drug classes used in the treatment, and the results from major clinical trials. This chapter will also present evidence-based recommendations and protocols for applying thrombolytic therapy to ...
Raul Nogueira, Lee H. Schwamm
openaire +1 more source
This chapter will review the basic mechanisms of clot formation (thrombosis) and dissolution (thrombolysis or fibrinolysis), the mechanisms of the major drug classes used in the treatment, and the results from major clinical trials. This chapter will also present evidence-based recommendations and protocols for applying thrombolytic therapy to ...
Raul Nogueira, Lee H. Schwamm
openaire +1 more source
Intracranial tumour haemorrhage following intravenous thrombolysis
Journal of Clinical Neuroscience, 2016Intravenous administration of thrombolytic agents is considered to be contraindicated in patients with intracranial neoplasms. However, only a single case of thrombolysis-related intracranial tumour haemorrhage has been reported to our knowledge and several studies have suggested that systemic thrombolysis can be safely carried out in these patients ...
Christian, Diehl +4 more
openaire +2 more sources
Coronary Thrombolysis with Intravenous Streptokinase
Cardiology Clinics, 1987Coronary thrombolysis can be achieved with several lytic agents administered via the intravenous or intracoronary routes. Streptokinase, when administered intravenously, produces coronary thrombolysis in from 34 to 75 per cent of patients. Intravenous administration has the advantage of rapid administration without the risks or delays inherent in the ...
openaire +2 more sources
Intravenous thrombolysis for stroke
BMJ, 2010Elderly patients should not be excluded solely on the basis of age Intravenous thrombolytic treatment for acute ischaemic stroke is controversial in patients over 80 years, mainly because they have been excluded from or under-represented in the large scale randomised controlled trials of such treatment.1 2 3 In the linked study (doi:10.1136/bmj.c6046),
openaire +1 more source